COVID-19 and Gender-Based Violence in Jordan Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
'Women's Issues'
Journal of International Women's Studies Volume 21 Issue 1 Article 21 February 2020 The Time to Question, Rethink and Popularize the Notion of ‘Women’s Issues’: Lessons from Jordan’s Popular and Labor Movements from 2006 to now Sara Ababneh Follow this and additional works at: https://vc.bridgew.edu/jiws Part of the Women's Studies Commons Recommended Citation Ababneh, Sara (2020). The Time to Question, Rethink and Popularize the Notion of ‘Women’s Issues’: Lessons from Jordan’s Popular and Labor Movements from 2006 to now. Journal of International Women's Studies, 21(1), 271-288. Available at: https://vc.bridgew.edu/jiws/vol21/iss1/21 This item is available as part of Virtual Commons, the open-access institutional repository of Bridgewater State University, Bridgewater, Massachusetts. This journal and its contents may be used for research, teaching and private study purposes. Any substantial or systematic reproduction, re-distribution, re-selling, loan or sub-licensing, systematic supply or distribution in any form to anyone is expressly forbidden. ©2020 Journal of International Women’s Studies. The Time to Question, Rethink and Popularize the Notion of ‘Women’s Issues’: Lessons from Jordan’s Popular and Labor Movements from 2006 to now By Sara Ababneh1 Abstract Jordanian women were an integral part of the Jordanian Popular Movement (al Hirak al Sha’bi al Urduni, Hirak in short) protests in 2011/2012. Yet, despite their large numbers and presence, female protestors did not call for any of the commonly known ‘women’s issues’ (qadaya al mar’a) which include fighting Gender Based Violence (GBV), legal reform, increasing women’s political participation, and women’s economic empowerment. -
Global Health Funding Cuts in H.R. 1: Projecting the Human Cost Lives at Stake: in February 2011, the U.S
February 2011 The Foundation for AIDS Research ISSUE BRIEF Global Health Funding Cuts in H.R. 1: Projecting the Human Cost Lives at Stake: In February 2011, the U.S. House of Representatives passed a Continuing Resolution (H.R. 1) to fund the federal government The Potential Annual Human Impact of through the rest of the fiscal year. The legislation would cut more Reducing Bilateral Global Health than $100 billion from the President’s FY 2011 budget request Funding to H.R. 1 Levels and represents the largest spending reduction in Congressional history. • Funding for AIDS treatment for 448,866 people would be eliminated, resulting in a halt to treatment Global health programs represent a high-impact expansion and deeper cuts in HIV prevention and other areas in an effort to avoid removing current investment, advancing American security, patients from lifesaving treatment. diplomatic, and humanitarian objectives. • 299,294 orphans and vulnerable children could lose their food, education, and livelihood assistance. U.S. investments in global health account for only one-quarter • 20,000 more infants could be infected with HIV of 1% of the U.S. budget and they save literally millions of each year due to reductions in services to combat lives each year. These global health programs (through the mother-to-child HIV transmission. President’s Global Health Initiative, bilateral AIDS funding for PEPFAR, and the Global Fund to Fight AIDS, Tuberculosis • Nearly 3.9 million fewer people would be treated and Malaria) represent a high-impact investment, advancing for malaria and 2 million fewer insecticide-treated American security, diplomatic, and humanitarian objectives. -
Uncertain Livelihoods in Refugee Environments Between Risk and Tradition for Syrian Refugee Women in Jordan Report 15
Researching livelihoods and services affected by conflict Uncertain livelihoods in refugee environments Between risk and tradition for Syrian refugee women in Jordan Report 15 Holly A Ritchie February 2017 Written by Holly A Ritchie SLRC reports present information, analysis and key policy recommendations on issues relating to livelihoods, basic services and social protection in conflict affected situations. This and other SLRC reports are available from www.securelivelihoods.org. Funded by DFID, Irish Aid and EC. The views presented in this paper are those of the author(s) and not necessarily the views of SLRC, DFID, Irish Aid and EC. ©SLRC 2017. Readers are encouraged to quote or reproduce material from SLRC for their own publications. As copyright holder SLRC, requests due acknowledgement and a copy of the publication. Secure Livelihoods Research Consortium Overseas Development Institute (ODI) 203 Blackfriars Road London SE1 8NJ United Kingdom T +44 (0)20 7922 8249 F +44 (0)20 7922 0399 E [email protected] www.securelivelihoods.org Cover photo: Image discouraging early-marriage in Zaatari camp, Jordan. Credit: UN Women/Christopher Herwig About us The Secure Livelihoods Research Consortium (SLRC) is a six-year project funded by DFID, Irish Aid and EC. SLRC aims to bridge the gaps in knowledge about: ■ When it is appropriate to build secure livelihoods in conflict-affected situations (CAS) in addition to meeting immediate acute needs; ■ What building blocks (e.g. humanitarian assistance, social protection, agriculture and basic services) are required in different contexts; ■ Who can best deliver building blocks to secure livelihoods in different contexts; and ■ How key investments can be better and more predictably supported by effective financing mechanisms. -
Amfar India to Benefit Amfar, the Foundation for AIDS Research
amfAR India To Benefit amfAR, The Foundation for AIDS Research November 2014 Mumbai, India Event Produced by Andy Boose / AAB Productions A Golden Opportunity amfAR held its inaugural Indian fundraising gala in Mumbai in November 2013. The event was hosted by amfAR Global Fundraising Chairman Sharon Stone, and Bollywood stars Aishwarya Rai Bachchan and Abhishek Bachchan. It was chaired by amfAR Chairman Kenneth Cole, Vikram Chatwal, Anuj Gupta, Rocky Malhotra, and Hilary Swank. Memorable Moments The black-tie event, presented by Dr. Cyrus Poonawalla and held at The Taj Mahal Palace Hotel, featured a cocktail reception, dinner, and an exquisite gold-themed fashion show that showcased three of India’s most important fashion designers -- Rohit Bal, Abu Jani- Sandeep Khosla, and Tarun Tahiliani. The evening concluded with a spirited performance by pop sensation Ke$ha, whose Hilary Swank for amfAR India songs included her hits Animal, We R Who We R, and Tik Tok. Among the Guests Neeta Ambani, Torquhil Campbell, Duke of Argyll, Sonal Chauhan, Venugopal Dhoot, Nargis Fakhri, Sunil Gavaskar, Parmeshwar Godrej, Lisa Haydon, Dimple Kapadia, Tikka Kapurthala, Nandita Mahtani, Rocky The Love Gold Fashion Show for amfAR India Abhishek Bachchan, Sharon Stone, Nita Ambani, and Aishwarya Rai Bachchan for amfAR India Malhotra, Dino Morea, among many others. Kenneth Cole and Sharon Stone for amfAR India Total Media Impressions: 2.4 Billion Total Media Value: $1.6 Million Aishwarya Rai Bachchan for amfAR India The Love Gold Fashion Show for amfAR India A Star-Studded Cast amfAR’s fundraising events are world renowned for their ability to attract a glittering list of top celebrities, entertainment industry elite, and international society. -
Columbia Global Centers Amman 2015 Annual
“Rather than observing world events from a distance, our students and faculty who A Message from Lee C. Bollinger travel to the global centers With the opening of global centers in Amman and Beijing in 2009, Columbia began an initiative that has become central to our understanding of what it means to be a global university. Amman and Beijing have been joined by six additional Columbia Global Centers, producing a network across four continents that is bringing together great find themselves immersed minds from diverse backgrounds to meet the challenges of our time. in those events and learning The potential of the Columbia Global Centers to provide the intellectual leadership for addressing their regions’ daunting challenges was apparent from the outset. With each passing year, more and more of that potential is being realized, and the results have been gratifying and at times inspiring. The pages of this report set forth those in unique ways from the achievements. All who know the Amman Center are well aware that this growth would not have occurred without the steadfast support of so many. Professor Safwan Masri, Columbia’s Executive Vice President for Global Centers experience.” and Global Development, deserves recognition for his role, as well. At the Columbia Global Centers, Columbia students and faculty are encountering some of the leading figures from Lee C. Bollinger every corner of the globe: innovative scholars, former heads of state, government officials, policy makers, and leaders of industry. This past year, each center hosted a rich variety of programs and events: from workshops assessing the President, Columbia University impact of the refugee crisis on global public health in Amman, to lectures on immigration and African-American cinema in Rio de Janeiro, to panels on women’s rights in Beijing and many more. -
Antiretroviral Drug-Related Liver Mortality Among HIV-Positive
HIV/AIDS MAJOR ARTICLE Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study Helen Kovari,1 Caroline A. Sabin,2 Bruno Ledergerber,1 Lene Ryom,3 Signe W. Worm,3 Colette Smith,2 Andrew Phillips,2 Peter Reiss,4 Eric Fontas,5 Kathy Petoumenos,6 Stéphane De Wit,7 Philippe Morlat,8 Jens D. Lundgren,3 and Rainer Weber1 1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland; 2Research Department of Infection and Population Health, Division of Population Health, Royal Free and University College, London, United Kingdom; 3Copenhagen HIV Programme, University of Copenhagen, Denmark; 4HIV Monitoring Foundation, Academic Medical Center, Amsterdam, The Netherlands; 5Département de Santé Publique, Centre Hospitalier Universitaire, Nice, France; 6National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia; 7Department of Infectious Diseases, St Pierre University Hospital, Brussels, Belgium; and 8Service de Medicine Interne et Maladies Infectieuses, Hopital Saint-André, CHU de Bordeaux, France Background. Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)–positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality. Methods. All patients in the Data Collection on Adverse Events of Anti-HIV Drugs study without HCV or HBV coinfection were prospectively followed from date of entry until death or last follow-up. -
CD4:CD8 Ratio Comparison Between Cohorts of HIV-Positive Asians and Caucasians Upon Commencement of Antiretroviral Therapy
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Antivir Manuscript Author Ther. Author manuscript; Manuscript Author available in PMC 2018 May 03. Published in final edited form as: Antivir Ther. 2017 ; 22(8): 659–668. doi:10.3851/IMP3155. CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy Kathy Petoumenos1, Jun Yong Choi2, Jennifer Hoy3, Sasisopin Kiertiburanakul4, Oon Tek Ng5, Mark Boyd6, Reena Rajasuriar7,8, and Matthew Lawon1 on behalf of the Australian HIV Observational Database and the TreatAsia HIV Observational Database 1The Kirby Institute, UNSW Australia, UNSW Sydney NSW 2052, Australia 2Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea 3Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Australia 4Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 5Department of Infectious Disease and Communicable Disease Centre, Tan Tock Seng Hospital, Singapore, Singapore 6University of Adelaide, Adelaide, South Australia 5005, Australia 7Centre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia 8Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract Background—In the era of effective antiretroviral treatment (ART) CD4:CD8 ratio is proposed as a potential marker for HIV-positive (HIV+) patients at increased risk for non-AIDS comorbidities. The current study aims to compare CD4:CD8 ratio between Asian and Caucasian HIV+ patients. Methods—HIV+ patients from the Australian HIV Observational Database (AHOD) and the TREAT Asia HIV Observational Database (TAHOD) meeting specific criteria were included. In these analyses Asian and Caucasian status were defined by cohort. -
Women and Gender in Middle East Politics
POMEPS STUDIES 19 Women and Gender in Middle East Politics May 10, 2016 Contents Reexamining patriarchy, gender, and Islam Conceptualizing and Measuring Patriarchy: The Importance of Feminist Theory . 8 By Lindsay J. Benstead, Portland State University Rethinking Patriarchy and Kinship in the Arab Gulf States . 13 By Scott Weiner, George Washington University Women’s Rise to Political Office on Behalf of Religious Political Movements . 17 By Mona Tajali, Agnes Scott College Women’s Equality: Constitutions and Revolutions in Egypt . 22 By Ellen McLarney, Duke University Activism and identity Changing the Discourse About Public Sexual Violence in Egyptian Satellite TV . 28 By Vickie Langohr, College of the Holy Cross Egypt, Uprising and Gender Politics: Gendering Bodies/Gendering Space . 31 By Sherine Hafez, University of California, Riverside Women and the Right to Land in Morocco: the Sulaliyyates Movement . 35 By Zakia Salime, Rutgers University The Politics of the Truth and Dignity Commission in Post-Revolutionary Tunisia: Gender Justice as a threat to Democratic transition? . 38 By Hind Ahmed Zaki, University of Washington Women’s political participation in authoritarian regimes First Ladies and the (Re) Definition of the Authoritarian State in Egypt . 42 By Mervat F. Hatem, Howard University Women’s Political Representation and Authoritarianism in the Arab World . 45 By Marwa Shalaby, Rice University The Future of Female Mobilization in Lebanon, Morocco, and Yemen after the Arab Spring . 52 By Carla Beth Abdo, University of Maryland -
Family, Islam, and Patriarchal Gender Roles
Obstacles to Women’s Political Empowerment in Jordan: Family, Islam, and Patriarchal Gender Roles Margaret W. Pettygrove Independent Study Project SIT Jordan 11 May 2006 Margaret Pettygrove Dr. Lamis Nasser, Advisor Lindsey Fauss, Academic Director, SIT Jordan Independent Study Project 11 May 2006 Pettygrove 1 Abstract Recent developments in women’s legislative rights in Jordan, and rising interest in women’s issues throughout the world, have sparked interest in women’s political participation. The purpose of this study is to investigate why, despite numerous advancements for women in Jordanian society, women have not gained greater representation in political processes. This study is based primarily on interviews with 15 Jordanian women between the ages of 18 and 36, as well as interviews with 6 professionals in the field of women’s studies in Jordan. The results of these interviews were analyzed within a theoretical framework provided by literary sources. Research was focused on four independent variables—family, Islam, women’s civil society organizations, and the quota for women in Parliament introduced in 2003—and the ways in which they inhibit or assist women’s political participation. Political participation in this study denotes participation, in roles of decision-making and leadership, in both civil society and political processes. The results of the research indicate that the family structure and the process of socialization within the family serve as obstacles to women’s political empowerment, as does the system of Islamic values in Jordan. The activities of women’s civil society organizations in Jordan hamper women’s abilities to achieve empowerment because they do not facilitate women’s participation in decision-making roles. -
ISSUE BRIEF AIDS Research: Broad Health and Economic Benefits
The Foundation for AIDS Research July 2011 ISSUE BRIEF AIDS Research: Broad Health and Economic Benefits Investments in health research at the National Institutes of Health (NIH) have paid enormous dividends in the health and well-being of people in the U.S. and around the world. HIV and AIDS research supported by NIH has yielded important recent advances and holds great promise for significantly reducing HIV infection rates and providing more effective treatments for people living with HIV/AIDS. Yet years of erratic funding levels for NIH and declining purchasing power have undermined our nation’s leadership in health research and our scientists’ ability to take advantage of the expanding opportunities to advance healthcare. The race to find better treatments and cures for cancer, heart Funding for AIDS and overall NIH health research, FY2003–FY2011, in current and inflation-adjusted dollars. The red lines show funding in disease, AIDS, and other diseases—and to control global constant 2003 dollars and show the progressive loss of purchasing power epidemics such as AIDS, tuberculosis, and malaria—depends for AIDS and overall health research funding. (Source: Office of AIDS on robust long-term investment in health research at NIH. Research, National Institutes of Health) Extraordinary Accomplishments in AIDS Research The U.S. has been the global leader in research to prevent and 1982: Scientists name a new disease, acquired treat HIV/AIDS and related serious health conditions. Over the immune deficiency syndrome (AIDS), a year after its past decades, the comprehensive AIDS research program at the discovery. NIH has led to scientific advances that have saved the lives of millions of people with HIV/AIDS and prevented millions more from 1984: American and French scientists confirm that becoming infected. -
Financial Statements Together with Report of Independent Certified Public Accountants
Financial Statements Together with Report of Independent Certified Public Accountants THE FOUNDATION FOR AIDS RESEARCH (formerly known as The American Foundation for AIDS Research) September 30, 2019 and 2018 Contents Page Report of Independent Certified Public Accountants 3 Financial Statements Statements of Financial Position as of September 30, 2019 and 2018 5 Statements of Activities for the years ended September 30, 2019 and 2018 6 Statement of Functional Expenses for the year ended September 30, 2019 7 Statement of Functional Expenses for the year ended September 30, 2018 8 Statements of Cash Flows for the years ended September 30, 2019 and 2018 9 Notes to the Financial Statements 10 GRANT THORNTON LLP REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS 757 Third Ave., 9th Floor New York, NY 10017-2013 D 212 599 0100 F 212 370 4520 S linkd.in/grantthorntonus To the Board of Trustees of twitter.com/grantthorntonus The Foundation for AIDS Research: We have audited the accompanying financial statements of The Foundation for AIDS Research (a New York not-for-profit corporation, also known as “amfAR”), which comprise the statements of financial position as of September 30, 2019 and 2018, and the related statements of activities, functional expenses and cash flows for the years then ended, and the related notes to the financial statements. Management’s responsibility for the financial statements Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error. -
Approaching a Cure for AIDS Defining an AIDS Cure
Approaching a Cure for AIDS Jeffrey Laurence, M.D. Senior Scientific Consultant for Programs, amfAR Professor of Medicine, Weill Cornell Medical College www.amfar.org www.amfar.org Defining an AIDS Cure Definition: “Treat a disease such that the patient no longer needs to continue treatment, as opposed to suppression or management of the disease as is presently required in diabetes, rheumatoid arthritis, and HIV.” * Specific: Functional vs. sterilizing cures *Fauci A. XVIIth International AIDS Conference, www.amfar.org Mexico City, Aug 3-8, 2008, Abst WESS0101 1 We want to cure HIV. “Viruses can’t be cured.” “Viruses can’t be cured…so far” •In 2009, NIAID spent $41million on HIV cure research, 3% of budget •(~$600million spent on vaccine research) •amfAR filling the gaping hole www.amfar.org A Cure for AIDS •AS Fauci: “We need a cure for AIDS.”* •ART is a life-long commitment •Current ART, and likely every newly developed antiretroviral drug, will have long-term, potentially life-limiting, adverse effects •2.7 million people were newly HIV infected in 2007, with ART reaching only 30% of those who needed it •It is unlikely that we can treat our way out of this pandemic: For every person started on ART, 2-3 are newly infected *Fauci A. XVIIth International AIDS Conference, www.amfar.org Mexico City, Aug 3-8, 2008, Abst WESS0101 2 “The U.S. spends about $20 billion every year on AIDS (both for programs in the U.S. and globally). The money is keeping millions of people alive around the world and preventing millions of infections.